-
Trailblazing Treatment: How a New Leukemia Treatment Helped 13-Year-Old Athlete Colin Campbell Fight Cancer and Stay Active
21 Jul 2025 21:00 GMT
… barely swallow.”
After visiting a doctor, Colin was sent to the … to hear that you have cancer.”
Colin, who is a … 87 percent. Because this clinical trial studied this ... his overall … 1/2 years of treatment. On blinatumomab —administered through a backpack …
-
After CAR T in Mantle Cell Lymphoma, Choices and a Robust Pipeline
18 Jul 2025 10:06 GMT
… trial (NCT02601313),2 offering hope in this rare form of non-Hodgkin lymphoma … ;cancers17132239.
Duarte C, Major A. Treatment of TP53-mutated mantle cell lymphoma: … #47;www.fda.gov/drugs/;resources-information-approved-drugs/fda-grants-accelerated- …
-
Across Cancer Types, Trispecific Antibodies Show Promise in Early Result
16 Jul 2025 20:00 GMT
… FDA granted fullantibody blinatumomab (Blincyto) in 2017 for the treatment … at Amsterdam University Medical Center, Vrije Universiteit … 2 dose optimization trial (NCT06440057), 17 patients … et al. FDA approval: blinatumomab. Clin Cancer Res. 2015;21 …
-
New leukemia drug offers hope for Iowa family and others
16 Jul 2025 23:49 GMT
… year, clinical trials for blinatumomab ended early due to the drug';s … , the most common childhood cancer.
"This is the closest … #47;2 years of treatment for leukemia, and her hair … doctors for where we are going to be in 10 years."
Blinatumomab …
-
Ponatinib Shows Promise in PhALLCON Study for Ph+ ALL Treatment
11 Jul 2025 18:00 GMT
… be mitigated in the PhALLCON trial, where a reduced dosing strategy … .
He also acknowledged that the treatment landscape for Ph+ ALL is … earlier in the treatment course. Agents such as blinatumomab (Blincyto) are now …
-
Witness to a Revolution: A Blood Cancer Expert’s Long View
11 Jul 2025 10:24 GMT
… in blood cancer care, especially for the treatment of Philadelphia … countries. We have targeted drugs that provide better survival, … dasatinib-blinatumomab trial in The New England Journal of Medicine in … offered was transplant.
The pill would obviously be the …
-
Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer Treatment
10 Jul 2025 17:18 GMT
… drug-conjugates (ADCs), immune checkpoint blockade, adoptive cell therapy, and cancer vaccines … treatment of HER2-positive breast cancer.24 Bispecific antibodies (bsAbs) like blinatumomab … cellular and pharmaceutical approaches. … -cell non-Hodgkin’s lymphoma in …
-
Bispecific Antibody Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight
07 Jul 2025 17:00 GMT
… . Beyond cancer treatment, bispecific … Blinatumomab has received orphan drug status from the U.S. FDA … Non-Hodgkin’s lymphoma and diffuse large B-cell lymphoma … Bellicum Pharmaceuticals, Kecellitics Biotech Company, Yake Biotechnology, Minerva Biotechnologies, …
-
ASCO 2025: Age-Related Differences in Relapsed/Refractory ALL Treatment Outcomes
01 Jul 2025 18:08 GMT
… analysis of the FELIX trial (NCT04404660), obecabtagene autoleucel … treatment and without a clear cause, according to the Leukemia & Lymphoma … Cel
Despite previous clinical trials demonstrating tolerable efficacy … vs 8.3%), prior blinatumomab use (53.2% …
-
Rethinking CML Treatment: How New Treatments Are Improving Patient Medication Compliance and Adherence
15 May 2025 13:43 GMT
Cilta-Cel Improves QOL, Extends Treatment Breaks vs SOC in R… Expression During AML Induction Chemo
Blinatumomab-Linked ICANS Cases Higher Than …
About
© 1995-2025